United States securities and exchange commission logo





                          May 25, 2021

       Brian Sun, Esq.
       Senior Vice President and General Counsel
       Sorrento Therapeutics, Inc.
       4955 Directors Place
       San Diego, CA 92121

                                                        Re: Sorrento
Therapeutics, Inc.
                                                            Registration
Statement on Form S-3
                                                            Filed May 19, 2021
                                                            File No. 333-256304

       Dear Mr. Sun:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Alan
Campbell at 202-551-4224 with any questions.




                          Sincerely,


                          Division of Corporation Finance

                          Office of Life Sciences
       cc:                                              Samantha H. Eldredge,
Esq.